» Articles » PMID: 36479439

RNA G-quadruplex Forming Regions from SARS-2, SARS-1 and MERS Coronoviruses

Overview
Journal Front Chem
Specialty Chemistry
Date 2022 Dec 8
PMID 36479439
Authors
Affiliations
Soon will be listed here.
Abstract

COVID-19 (Corona Virus Disease 2019), SARS (Severe Acute Respiratory Syndrome) and MERS (Middle East Respiratory Syndrome) are infectious diseases each caused by coronavirus outbreaks. Small molecules and other therapeutics are rapidly being developed to treat these diseases, but the threat of new variants and outbreaks argue for the identification of additional viral targets. Here we identify regions in each of the three coronavirus genomes that are able to form G-quadruplex (G4) structures. G4s are structures formed by DNA or RNA with a core of two or more stacked planes of guanosine tetrads. In recent years, numerous DNA and RNA G4s have emerged as promising pharmacological targets for the treatment of cancer and viral infection. We use a combination of bioinformatics and biophysical approaches to identify conserved RNA G4 regions from the ORF1A and S sequences of SARS-CoV, SARS-CoV-2 and MERS-CoV. Although a general depletion of G4-forming regions is observed in coronaviridae, the preservation of these selected G4 sequences support a significance in viral replication. Targeting these RNA structures may represent a new antiviral strategy against these viruses distinct from current approaches that target viral proteins.

Citing Articles

G-quadruplex formation in RNA aptamers selected for binding to HIV-1 capsid.

Mayer M, Lange M Front Chem. 2024; 12:1425515.

PMID: 39502140 PMC: 11536715. DOI: 10.3389/fchem.2024.1425515.


A Branched SELEX Approach Identifies RNA Aptamers That Bind Distinct HIV-1 Capsid Structural Components.

Gruenke P, Mayer M, Aneja R, Schulze W, Song Z, Burke D ACS Infect Dis. 2024; 10(8):2637-2655.

PMID: 39016538 PMC: 11320578. DOI: 10.1021/acsinfecdis.3c00708.


From RNA sequence to its three-dimensional structure: geometrical structure, stability and dynamics of selected fragments of SARS-CoV-2 RNA.

Gorb L, Voiteshenko I, Hurmach V, Zarudnaya M, Nyporko A, Shyryna T NAR Genom Bioinform. 2024; 6(2):lqae062.

PMID: 38835951 PMC: 11148665. DOI: 10.1093/nargab/lqae062.


Abundance of G-Quadruplex Forming Sequences in the Hepatitis Delta Virus Genomes.

Brazda V, Valkova N, Dobrovolna M, Mergny J ACS Omega. 2024; 9(3):4096-4101.

PMID: 38284014 PMC: 10809645. DOI: 10.1021/acsomega.3c09288.


G-Quadruplexes in the Viral Genome: Unlocking Targets for Therapeutic Interventions and Antiviral Strategies.

Pathak R Viruses. 2023; 15(11).

PMID: 38005893 PMC: 10674748. DOI: 10.3390/v15112216.


References
1.
Lista M, Martins R, Billant O, Contesse M, Findakly S, Pochard P . Nucleolin directly mediates Epstein-Barr virus immune evasion through binding to G-quadruplexes of EBNA1 mRNA. Nat Commun. 2017; 8:16043. PMC: 5504353. DOI: 10.1038/ncomms16043. View

2.
Ziegler C, Allon S, Nyquist S, Mbano I, Miao V, Tzouanas C . SARS-CoV-2 Receptor ACE2 Is an Interferon-Stimulated Gene in Human Airway Epithelial Cells and Is Detected in Specific Cell Subsets across Tissues. Cell. 2020; 181(5):1016-1035.e19. PMC: 7252096. DOI: 10.1016/j.cell.2020.04.035. View

3.
Sisk J, Frieman M, Machamer C . Coronavirus S protein-induced fusion is blocked prior to hemifusion by Abl kinase inhibitors. J Gen Virol. 2018; 99(5):619-630. PMC: 6537626. DOI: 10.1099/jgv.0.001047. View

4.
Metifiot M, Amrane S, Litvak S, Andreola M . G-quadruplexes in viruses: function and potential therapeutic applications. Nucleic Acids Res. 2014; 42(20):12352-66. PMC: 4227801. DOI: 10.1093/nar/gku999. View

5.
Wang Y, Han G, Jiang X, Yuwen T, Xue Y . Chemical shift prediction of RNA imino groups: application toward characterizing RNA excited states. Nat Commun. 2021; 12(1):1595. PMC: 7952389. DOI: 10.1038/s41467-021-21840-x. View